Session Description

As early phase oncology trials grow more complex, sponsors and CROs are rethinking how studies are operationalized to improve enrollment, execution and patient experience. Increasingly, success depends on putting the site perspective at the forefront of trial planning and delivery.

This session explores what integrated oncology site networks are telling sponsors and CROs about running early phase oncology trials today. Drawing on real‑world insights from site partners, the discussion highlights how a site‑first operational design, strategic collaboration and deeper understanding of priorities can reduce execution risk, accelerate start‑up and support a more effective and patient‑centric trial journey from planning through delivery.

Key Takeaways

• Understand what oncology site networks are telling sponsors and CROs about enrollment, engagement and retention in early phase trials
• Learn why putting site needs and operational realities at the forefront of trial design improves execution and patient experience
• See how practical, site‑first operational design decisions can accelerate start‑up and improve overall trial performance